Prospects of IL-2 in Cancer Immunotherapy

BioMed Research International - United States
doi 10.1155/2018/9056173
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Prospects for Exosomes in Immunotherapy of Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2006English

Dual Roles of IL-27 in Cancer Biology and Immunotherapy

Mediators of Inflammation
ImmunologyCell Biology
2017English

Revisiting IL-2: Biology and Therapeutic Prospects

Science immunology
AllergyImmunology
2018English

Bempegaldesleukin (NKTR-214): A CD-122-biased IL-2 Receptor Agonist for Cancer Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2019English

403. The Potential of Pro-Apoptotic PAC-1 Treatment for Augmentation of IL-2 Mediated Breast Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

IL-12 Immunotherapy of BrafV600E-induced Papillary Thyroid Cancer in a Mouse Model

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2015English

IL-9 BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer in Europe

Japanese Journal of Urology
Urology
2007English

Targeted IL-15-based Protein Fusion Complexes as Cancer Immunotherapy Approaches

Journal of Immunological Sciences
2018English

Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy